[1]陈晓梅 陈巧玮 曾纪娟 张庆.可穿戴设备在慢性心力衰竭患者管理中的应用进展[J].心血管病学进展,2023,(3):233.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.010]
　CHEN Xiaomei,CHEN Qiaowei,ZENG Jijuan,et al.Application of Wearable Devices in Management of Patients with Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2023,(3):233.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.010]
点击复制

可穿戴设备在慢性心力衰竭患者管理中的应用进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年3期
页码:
233
栏目:
综述
出版日期:
2023-03-25

文章信息/Info

Title:
Application of Wearable Devices in Management of Patients with Chronic Heart Failure
作者:
陈晓梅 陈巧玮 曾纪娟 张庆
(四川大学华西医院心脏内科,四川 成都 610041)
Author(s):
CHEN Xiaomei; CHEN Qiaowei; ZENG Jijuan; ZHANG Qing
(Department of Cardiology,West China Hospital of Sichuan University,Chengdu 610041,Sichuan,China)
关键词:
慢性心力衰竭; 院外管理; 可穿戴设备
Keywords:
Chronic heart failure; Post-hospital management; Wearable devices
DOI:
10.16806/j.cnki.issn.1004-3934.2023.03.010
摘要:
医院外随访是慢性心力衰竭诊治体系中必不可少的部分，是减少不良心血管事件的关键。目前多采用专科门诊、社区医院或电话随访等方式，定期进行病情监测和药物治疗优化。但这些随访方式间隔数周到数月，且受患者依从性影响，不能及时发现心力衰竭恶化先兆并干预。新兴的可穿戴设备是一种由患者日常佩戴的外部应用设备，可连续性获得患者居家状态下的多种生理参数，用于综合判断患者病情并预设报警，提供给心力衰竭管理专业团队进行干预，以弥补传统随访方式的不足。目前研发的可穿戴设备种类较多，在使用方法、参数采集、应用场景和解释方式上存在较大差异。现综述常用可穿戴设备在慢性心力衰竭患者管理中的应用，并讨论其在未来的应用前景。
Abstract:
Post-hospital management is an indispensable part of the diagnosis and treatment system of chronic heart failure,and is the key to reduce adverse cardiovascular events. At present,most of the patients are followed up at specialized clinics,community hospitals or telephone follow-up to regularly monitor the condition and optimize drug treatment. However,these follow-up methods vary from weeks to months,and are affected by the patient’s compliance,so they can not find the signs of heart failure deterioration and intervene in time. The emerging wearable device is an external application device that is worn by patients daily. It can continuously obtain a variety of physiological parameters of patients at home,which can be used to comprehensively judge the patient’s condition and preset the alarm,and provide it to the professional team of heart failure management for intervention to make up for the deficiency of the traditional follow-up method. At present,there are many kinds of wearable devices developed,and there are great differences in use methods,parameter collection,application scenarios and interpretation methods. This article reviews the application of commonly used wearable devices in the management of patients with chronic heart failure,and discusses its application prospects in the future

参考文献/References:

[1] Bozkurt B,Coats AJ,Tsutsui H,et al. Universal definition and classification of heart failure:a report of the Heart Failure Society of America,Heart Failure Association of the European Society of Cardiology,Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure[J]. J Card Fail,2021,27:387-413.

[2] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志,2018,46(10):30.
[3] Authors/Task Force Members,McDonagh TA,Metra M,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC). With the special contribution of the Heart Failure Association(HFA) of the ESC[J]. Eur J Heart Fail,2022,24(1):4-131.
[4] Varma N,Marrouche NF,Aguinaga L,et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic[J]. Heart Rhythm,2020,17(9):e255-e268.
[5] Fox K,Ford I,Steg PG,et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction(BEAUTIFUL):a subgroup analysis of a randomised controlled trial[J]. Lancet,2008,372(9641):817.
[6] Etiwy M,Akhrass Z,Gillinov L,et al. Accuracy of wearable heart rate monitors in cardiac rehabilitation[J]. Cardiovasc Diagn Ther,2019,9(3):262-271.
[7] Hahnen C,Freeman CG,Haldar N,et al. Accuracy of vital signs measurements by a smartwatch and a portable health device:validation study[J]. JMIR Mhealth Uhealth,2020,8(2):e16811.
[8] Reali P,Lolatto R,Coelli S,et al. Information retrieval from photoplethysmographic sensors:a comprehensive comparison of practical interpolation and breath-extraction techniques at different sampling rates[J]. Sensors(Basel),2022,22(4):1428.
[9] Cobos Gil Má. Standard and precordial leads obtained with an apple watch[J]. Ann Intern Med,2020,172(6):436-437.
[10] Dagher L,Shi H,Zhao Y,et al. Wearables in cardiology:here to stay[J]. Heart Rhythm,2020,17(5 Pt B):889-895.
[11] Kario K,Shimbo D,Tomitani N,et al. The first study comparing a wearable watch-type blood pressure monitor with a conventional ambulatory blood pressure monitor on in-office and out-of-office settings[J]. J Clin Hypertens(Greenwich),2020,22(2):135-141.
[12] Blond K,Brinkl? CF,Ried LM,et al. Association of high amounts of physical activity with mortality risk:a systematic review and meta-analysis[J]. Br J Sports Med,2020,54(20):1195-1201.
[13] Yang CC,Hsu YL. A review of accelerometry-based wearable motion detectors for physical activity monitoring[J]. Sensors(Basel),2010,10(8):7772-7788.
[14] Troiano RP,McClain JJ,Brychta RJ,et al. Evolution of accelerometer methods for physical activity research[J]. Br J Sports Med,2014,48(13):1019-1023.
[15] Bolanakis DE. MEMS barometers and barometric altimeters in industrial,medical,aerospace,and consumer applications[J]. IEEE Instrum Meas Mag,2017,20(6):30-38,55.
[16] Gastelurrutia P,Cuba-Gyllensten I,Lupon J,et al. Wearable vest for pulmonary congestion tracking and prognosis in heart failure:a pilot study[J]. Int J Cardiol,2016,215:77-79.
[17] Lee S,Squillace G,Smeets C,et al. Congestive heart failure patient monitoring using wearable Bio-impedance sensor technology[J]. Annu Int Conf IEEE Eng Med Biol Soc,2015,2015:438-441.
[18] Cuba Gyllensten I,Bonomi AG,Goode KM,et al. Early indication of decompensated heart failure in patients on home-telemonitoring:a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance[J]. JMIR Med Inform,2016,4(1):e3.
[19] Amir O,Azzam ZS,Gaspar T,et al. Validation of remote dielectric sensing(ReDS?) technology for quantification of lung fluid status:comparison to high resolution chest computed tomography in patients with and without acute heart failure[J]. Int J Cardiol,2016,221:841-846.
[20] Priori SG,Blomstr?-Lundqvist C,Mazzanti A,et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology(ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology(AEPC)[J]. Eur Heart J,2015,36(41):2793-2867.
[21] Duncker D,Veltmann C. Role of the wearable defibrillator in newly diagnosed heart failure[J]. Curr Heart Fail Rep,2018,15(6):368-375.
[22] Hillmann HAK,Hohmann S,Mueller-Leisse J,et al. Feasibility and first results of heart failure monitoring using the wearable cardioverter-defibrillator in newly diagnosed heart failure with reduced ejection fraction[J]. Sensors(Basel),2021,21(23):7798.
[23] Werhahn SM,Dathe H,Rottmann T,et al. Designing meaningful outcome parameters using mobile technology:a new mobile application for telemonitoring of patients with heart failure[J]. ESC Heart Fail,2019,6(3):516-525.
[24] Burlacu A,Brinza C,Popa IV,et al. Influencing cardiovascular outcomes through heart rate variability modulation:a systematic review[J]. Diagnostics(Basel),2021,11(12):2198.
[25] Stehlik J,Schmalfuss C,Bozkurt B,et al. Continuous wearable monitoring analytics predict heart failure hospitalization:the LINK-HF multicenter study[J]. Circ Heart Fail,2020,13(3):e006513.
[26] Amir O,Ben-Gal T,Weinstein JM,et al. Evaluation of remote dielectric sensing(ReDS) technology-guided therapy for decreasing heart failure re-hospitalizations[J]. Int J Cardiol,2017,240:279-284.
[27] Heidenreich PA,Bozkurt B,Aguilar D,et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation,2022,145(18):e895-e1032.
[28] Thorup C,Hansen J,Gr?kj? M,et al. Cardiac patients’ walking activity determined by a step counter in cardiac telerehabilitation:data from the intervention arm of a randomized controlled trial[J]. J Med Internet Res,2016,18(4):e69.
[29] Tsai LL,McNamara RJ,Moddel C,et al. Home-based telerehabilitation via real-time videoconferencing improves endurance exercise capacity in patients with COPD:the randomized controlled TeleR Study[J]. Respirology,2017,22(4):699-707.
[30] Prescher S,Schoebel C,Koehler K,et al. Prognostic value of serial six-minute walk tests using tele-accelerometry in patients with chronic heart failure:a pre-specified sub-study of the TIM-HF-Trial[J]. Eur J Prev Cardiol,2016,23(2 suppl):21-26.
[31] Pahlevan NM,Rinderknecht DG,Tavallali P,et al. Noninvasive iPhone measurement of left ventricular ejection fraction using intrinsic frequency methodology[J]. Crit Care Med,2017,45(7):1115-1120.
[32] Kenny JS,Munding CE,Eibl JK,et al. A novel,hands-free ultrasound patch for continuous monitoring of quantitative Doppler in the carotid artery[J]. Sci Rep,2021,11(1):7780.

相似文献/References:

[1]戴玫,付珞,胡建英,等.慢性心力衰竭患者应用高强度间歇性有氧训练研究进展[J].心血管病学进展,2016,(3):271.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.014]
　DAI Mei,FU Luo,HU Jianying,et al.Advances in Research on High-intensity Interval Training in Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2016,(3):271.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.014]
[2]张培,综述,刘剑,等.慢性心力衰竭并发肌少症的研究进展[J].心血管病学进展,2016,(3):275.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.015]
　ZHANG Pei,LIU Jian.Research Progress in Chronic Heart Failure-induced Sarcopenia[J].Advances in Cardiovascular Diseases,2016,(3):275.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.015]
[3]田晶,张青,张岩波,等.慢性心力衰竭结局评价指标研究进展[J].心血管病学进展,2019,(6):931.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.023]
　TIAN Jing,ZHANG qing,ZHANG Yanbo,et al.Outcome Indicators for Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2019,(3):931.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.023]
[4]胡威,苏芳菊,张卫泽.左室四极导线在心脏再同步化治疗中的应用进展[J].心血管病学进展,2020,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
　HU Wei,SU Fangju,ZHANG Weize.Application of Left Ventricular Quadrupole in Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2020,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
[5]郭岐龙 芦颜美 张玲 张疆华 邢强 祖克拉·吐尔洪 李耀东 周贤惠 汤宝鹏.新疆地区老年慢性心力衰竭住院患者的病因、合并症及药物治疗的多中心回顾性分析[J].心血管病学进展,2020,(4):414.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.021]
　GUO Qilong,LU Yanmei,ZHANG Ling,et al.Etiology, Comorbidity and Drug Treatment of Elderly Inpatients with Chronic Heart Failure in Xinjiang: A Multi-center Retrospective Study[J].Advances in Cardiovascular Diseases,2020,(3):414.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.021]
[6]毛玉琳 何胜虎.2型糖尿病和慢性心力衰竭[J].心血管病学进展,2020,(5):491.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.012]
　MAO Yulin,HE Shenghu.Type 2 Diabetes Mellitus and Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2020,(3):491.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.012]
[7]郭曦滢,孙煌,樊朝美,等.非奈利酮治疗慢性心力衰竭的研究进展[J].心血管病学进展,2020,(10):1021.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.006]
　GUO XiyingSUN HuangFAN ChaomeiZHANG Jian.Finerenone in the Treatment of Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2020,(3):1021.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.006]
[8]吴燕婷 李萍 吴寒.慢性心力衰竭再住院率研究进展[J].心血管病学进展,2021,(8):691.[doi:10.16806/j.cnki.issn.1004-3934-2021.08.005]
　WU Yanting,LI Ping,WU Han.Rehospitalization Rate of Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2021,(3):691.[doi:10.16806/j.cnki.issn.1004-3934-2021.08.005]
[9]李彤 呼海娟 崔炜.慢性心力衰竭患者脑钠肽抵抗机制的研究进展[J].心血管病学进展,2023,(3):238.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.011]
　LI Tong,HU Haijuan,CUI Wei.Mechanism of Brain Natriuretic Peptide Tolerance in Patients with Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2023,(3):238.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.011]
[10]高亮 芦颜美.慢性心力衰竭并发肌少症和恶病质的诊治进展[J].心血管病学进展,2023,(7):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]
　GAO Liang,LU Yanmei.Diagnosis and Treatment of Chronic Heart Failure Complicated with Sarcopenia and Cachexia[J].Advances in Cardiovascular Diseases,2023,(3):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]

更新日期/Last Update: 2023-04-24